CODEXIS INC (CDXS) — insider trading
Health Care · NASDAQ
CODEXIS INC (CDXS) has 13 reported SEC Form 4 insider transactions in our data, including 2 open-market sales among the most recent 13 (latest 2026-06-17).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | De Vre Raymond | Director | Grant / award / vesting (derivative) | 66,350 | $0.00 | $0 | Form 4 |
| 2026-06-17 | DILLY STEPHEN GEORGE | Director | Grant / award / vesting (derivative) | 66,350 | $0.00 | $0 | Form 4 |
| 2026-06-17 | Martinborough Esther | Director | Grant / award / vesting (derivative) | 66,350 | $0.00 | $0 | Form 4 |
| 2026-06-17 | Singhvi Rahul | Director | Grant / award / vesting (derivative) | 66,350 | $0.00 | $0 | Form 4 |
| 2026-06-17 | Smith David V | Director | Grant / award / vesting (derivative) | 66,350 | $0.00 | $0 | Form 4 |
| 2026-06-17 | Richards Christos | Director | Grant / award / vesting (derivative) | 66,350 | $0.00 | $0 | Form 4 |
| 2026-06-17 | Collins Cynthia | Director | Grant / award / vesting (derivative) | 66,350 | $0.00 | $0 | Form 4 |
| 2026-06-17 | PARKER H STEWART | Director | Grant / award / vesting (derivative) | 66,350 | $0.00 | $0 | Form 4 |
| 2026-06-11 | De Vre Raymond | Director | Open-market sale | 2,605 | $2.37 | $6.2K | Form 4 |
| 2026-02-24 | Lutz Stefan | Officer (Chief Scientific Officer) | Open-market sale | 5,862 | $1.13 | $6.6K | Form 4 |
| 2026-02-23 | Erbez Georgia | Officer (See Remarks) | Grant / award / vesting (derivative) | 316,100 | $0.00 | $0 | Form 4 |
| 2026-02-23 | MOORE ALISON | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 993,000 | $0.00 | $0 | Form 4 |
| 2026-02-23 | Lutz Stefan | Officer (Chief Scientific Officer) | Grant / award / vesting (derivative) | 316,100 | $0.00 | $0 | Form 4 |
Ask the chat about CDXS's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CODEXIS INC (CDXS).
Last updated 2026-06-17 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.